See also this year's filing and all EDGAR filings for this company.
PDF Report 0001109196_2017_MABVAX_THERAPEUTICS_HOLDINGS_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001109196')"} |
Graph
Absolute values for 0001109196, MABVAX THERAPEUTICS HOLDINGS INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 4,293,978 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 6,826,003 |
| 2 | PropertyPlantAndEquipmentNet | 731,712 |
| 3 | remainder_Assets | 168,597 |
| 4 | LiabilitiesCurrent | 5,690,634 |
| 5 | LiabilitiesNoncurrent | 2,987,134 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,010,450 |
| 9 | ResearchAndDevelopmentExpense | 7,800,723 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 148,054 |
| 12 | remainder_NetIncome | -997,364 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 12,020,290 |
| 1 | Liabilities | 8,677,768 |
| 2 | Expenses | 16,811,173 |
| 3 | Revenues | 148,054 |
| 4 | StockholdersEquity | 3,342,522 |
| 5 | NetIncome | -17,660,483 |
| 6 | ComprehensiveNetIncome | -17,660,483 |
| 7 | BaseVar | 19,327,324 |
| 8 | EconomicCapitalRatio | -1.15 |
Edgar->Model Mapping
Feature Distribution
